The Klein Regulation Business Reminds Buyers of Course Actions on Behalf of Shareholders of QIWI, GDRX and TCDA

The MarketWatch News Department was not involved in the development of this content.

January 25, 2021 (ACCESSWIRE through COMTEX) —
NEW YORK, NY / ACCESSWIRE / January 25, 2021 / The Klein Regulation Organization announces that class motion grievances have been submitted on behalf of shareholders of the pursuing corporations. There is no price to take part in the fit. If you suffered a decline, you have until eventually the guide plaintiff deadline to request that the court appoint you as lead plaintiff.

Qiwi plc (NASDAQ:QIWI)

Class Period of time: March 28, 2019 – December 9, 2020

Direct Plaintiff Deadline: February 9, 2021

Qiwi plc allegedly made materially false and/or deceptive statements and/or unsuccessful to disclose that: (1) Qiwi’s interior controls associated to reporting and file-keeping have been ineffective (2) therefore, the Central Financial institution of Russia would impose a monetary wonderful on the Business and impose restrictions upon the Company’s capability to make payments to overseas merchants and transfer money to pre-compensated cards and (3) as a consequence, Defendants’ public statements were materially bogus and/or deceptive at all suitable occasions.

Understand about your recoverable losses in QIWI:

GoodRx Holdings, Inc (NASDAQ:GDRX)

Course Time period: September 23, 2020 – November 16, 2020

Guide Plaintiff Deadline: February 16, 2021

Throughout the course time period, GoodRx Holdings, Inc allegedly manufactured materially wrong and/or misleading statements and/or unsuccessful to disclose that: at the time of the IPO, unbeknownst to investors,, Inc. was developing and would before long introduce its own on line and cellular prescription medicine purchasing and success company that would directly contend with GoodRx. Defendants timed the IPO so that it was priced ahead of Amazon introduced its on the web pharmaceutical organization to facilitate the IPO and produce synthetic desire for the popular shares offered therein, as effectively to optimize the sum of funds the Company and the providing stockholders could raise in the IPO. Offered defendants’ know-how of Amazon’s intention to enter the on line pharmaceutical organization, and their deceptive statements about GoodRx’s competitive position made contemporaneously with that understanding, defendants’ materially false and/or deceptive statements alleged herein ended up produced willfully and brought on GoodRx popular stock to trade at artificially inflated price ranges all through the Class Time period.

Understand about your recoverable losses in GDRX:

Tricida, Inc. (NASDAQ:TCDA)

Class Time period: September 4, 2019 – Oct 28, 2020

Guide Plaintiff Deadline: March 8, 2021

Tricida, Inc. allegedly designed materially wrong and/or deceptive statements and/or unsuccessful to disclose that: (i) Tricida’s NDA for veverimer was materially deficient (ii) accordingly, it was foreseeably probable that the Fda would not acknowledge the NDA for veverimer and (iii) as a outcome, the Company’s general public statements have been materially wrong and deceptive at all pertinent moments.

Find out about your recoverable losses in TCDA:

Image: or photos/624899/image-20210119122730-1.png

Your means to share in any restoration isn’t going to require that you serve as a direct plaintiff. If you endured a reduction during the class period and want to get additional information and facts, remember to speak to J. Klein, Esq. by telephone at 212-616-4899 or stop by the webpages supplied.

J. Klein, Esq. represents traders and participates in securities litigations involving financial fraud during the nation. Legal professional promoting. Prior effects do not assurance very similar results.

Make contact with:

J. Klein, Esq.

Empire Point out Building

350 Fifth Avenue

59th Floor

New York, NY 10118

[email protected]

Telephone: (212) 616-4899

Fax: (347) 558-9665

Supply: The Klein Law Company

Check out resource variation on


Is there a trouble with this push release? Make contact with the source supplier Comtex at [email protected]. You can also make contact with MarketWatch Consumer Assistance by way of our Consumer Centre.

Copyright 2021 ACCESSWIRE

The MarketWatch Information Department was not concerned in the creation of this content material.